Efficacy and safety of abatacept in active primary Sjögren’s syndrome: results of a phase III, randomised, placebo-controlled trial

OBJECTIVES: To evaluate efficacy and safety of abatacept in adults with active primary Sjögren’s syndrome (pSS) in a phase III, randomised, double-blind, placebo-controlled trial. METHODS: Eligible patients (moderate-to-severe pSS [2016 ACR/European League Against Rheumatism (EULAR) criteria], EULAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Baer, Alan N, Gottenberg, Jacques-Eric, St Clair, E William, Sumida, Takayuki, Takeuchi, Tsutomu, Seror, Raphaèle, Foulks, Gary, Nys, Marleen, Mukherjee, Sumanta, Wong, Robert, Ray, Neelanjana, Bootsma, Hendrika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Sjögren's Syndrome
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892395/
https://www.ncbi.nlm.nih.gov/pubmed/33168545
http://dx.doi.org/10.1136/annrheumdis-2020-218599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892395/
https://www.ncbi.nlm.nih.gov/pubmed/33168545
http://dx.doi.org/10.1136/annrheumdis-2020-218599

Ejemplares similares